|
|
|
|
| LEADER |
00874nam 2200325#c 4500 |
| 001 |
UMA-3436 |
| 003 |
UMA |
| 005 |
20230415 193457 |
| 008 |
030304suuuu####sz###########||||#0#eng#d |
| 336 |
|
|
|a texto
|
| 337 |
|
|
|a no mediado
|
| 338 |
|
|
|a volumen
|
| 901 |
|
|
|a 6483
|
| 020 |
|
|
|a 9241545364
|
| 080 |
|
|
|a 615.11
|
| 092 |
|
|
|a REF. 615.11
|
| 245 |
|
|
|a The international pharmacopoeia
|
| 110 |
|
|
|a World Health Organization
|
| 650 |
|
|
|a Farmacopea
|
| 650 |
|
|
|a Farmacia
|
| 650 |
|
|
|a Pruebas
|
| 650 |
|
|
|a Métodos
|
| 650 |
|
|
|a Normas de calidad
|
| 650 |
|
|
|a Sustancias farmacéuticas
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|a sz#
|
| 500 |
|
|
|a Contenido: v.5 Test and general requirements for dosage formas ; Quality specifications for pharmaceutical substances and tablets
|
| 300 |
|
|
|a v. 5 ; 24 cm.
|
| 260 |
|
|
|a Geneva, Switzerland
|b WHO
|c 2003
|
| 250 |
|
|
|a 3rd. ed.
|